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2 
Abstract 19 
Moringa oleifera is an edible medicinal plant used to fight malnutrition in Africa. In this study, 20 
M. oleifera flowers, fruits and seeds from Guinea-Bissau were characterized for their nutritional 21 
composition and hydroethanolic and aqueous extracts were prepared to investigate the phenolic 22 
profiles and bioactivities. Seeds presented higher levels of proteins (~31 g/100 g dw), fat (~26 23 
g/100 g dw) and flavan-3-ol derivatives, while carbohydrates, proteins, citric acid, and 24 
glycosylated flavonoids were abundant in fruits and flowers, these last samples also being rich 25 
in α-tocopherol (~18 mg/100 g dw). Some of the identified polyphenols had never been 26 
described in M. oleifera. In general, hydroethanolic extracts contained more polyphenols and 27 
were more active against lipid peroxidation, NO production, and tumour cells growth. 28 
Significant antimicrobial effects against the tested bacteria and fungi strains were displayed by 29 
both hydroethanolic and aqueous extracts. The M. oleifera potential to fight malnutrition and 30 
health issues was highlighted. 31 
 32 
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1. Introduction  36 
The search for plants and plant-based products that can face the raising necessities of food and 37 
medicines in a context of climate changes and food scarcity is nowadays a major challenge in 38 
Africa where persist malnutrition problems (Muyonga et al., 2016). In this context, Moringa 39 
oleifera Lam. (Moringaceae) appears as a species with nutritional, medicinal and agronomic 40 
value. This fast-growing, deciduous tree is native to the Indian subcontinent and Pakistan, and 41 
has become naturalized in the tropical and subtropical areas around the world, namely in many 42 
African countries due to its easy adaptability and tolerance to a wide range of environmental 43 
conditions regarding climate and soil (Daba, 2016). 44 
M. oleifera is one of the most auspicious plants used as a suitable alternative for preventing and 45 
alleviating malnutrition challenges, especially hidden hunger health issues (Padayachee & 46 
Baijnath, 2019). It is considered to be a “Miracle tree” or “Tree of life” due to the substantial 47 
beneficial effects that it has on health, but also due to its potential use in water sanitation and 48 
environmental conservation (Daba, 2016). M. oleifera preparations have been reported in the 49 
scientific literature as having a wide range of pharmacological properties, including 50 
antimicrobial, hypotensive, hypoglycemic, immunomodulatory, and anti-inflammatory 51 
activities. In addition, all M. oleifera parts (including leaves, fruits, seeds, pods, and flowers) 52 
have been used in traditional foods and dishes for human consumption (Daba, 2016).  53 
The leaves and seeds are eaten fresh, powdered or cooked and contain a varied profile of 54 
nutrients and health-promoting compounds, such as fatty acids, tocopherols, β-carotene, and 55 
phenolic compounds. The fruits are fibrous and traditionally used to treat digestive problems 56 
and prevent colon cancer. Flower extracts, in turn, are used in culinary preparations to enhance 57 
the taste and colour of dishes (Padayachee & Baijnath, 2019; Ziani et al., 2019). These M. 58 
oleifera organs are also known to be good sources of secondary metabolites, including 59 
terpenoids, flavonoids, tannins, anthocyanins, and proanthocyanidins (Ajibade et al., 2013). 60 
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These bioactive compounds contribute to the therapeutic and medicinal properties of M. 61 
oleifera and may justify its uses by the indigenous system of medicine in the treatment of 62 
common ailments and disorders, such as anaemia, asthma, diarrhea, skin infections, headaches, 63 
swelling, hysteria, cholera, scurvy, respiratory disorders, diabetes, cough, sore throat, and chest 64 
congestion (Padayachee & Baijnath, 2019). Therefore, this edible medicinal plant appears as a 65 
natural remedy easily accessible to populations in developing countries that need basic 66 
healthcare, especially in areas where Western medicine is inaccessible or expensive 67 
(Padayachee & Baijnath, 2019). Curiously, M. oleifera seed powder is used as a purifying agent 68 
in the treatment of water, being able to eliminate pathogenic bacteria up to 99%, whereas fresh 69 
leaves can be used to extract a juice used as a growth hormone (or soil fertilizer) able to increase 70 
crop yields by 25-35% (Daba, 2016). 71 
In Guinea-Bissau (West Africa), the awareness of local populations about the medicinal and 72 
nutritional properties of M. oleifera has increased in the last years, where the trade of seeds and 73 
dried and crushed leaves is under development. Despite this, the exploitation of the different 74 
edible and medicinal parts of this plant in this country is far to reach their full potential 75 
(Bancessi et al., 2019). Therefore, due to the multiple traditional uses and applications of M. 76 
oleifera, this study was performed to determine the detailed nutritional and chemical 77 
composition (proximate constituents, free sugars, organic acids, tocopherols, fatty acids, and 78 
phenolic compounds) of seed, flower and fruit samples collected in two distinct locations in 79 
Guinea-Bissau using official methods of food analysis and advanced chromatographic 80 
techniques. In addition, the antioxidant, anti-inflammatory, cytotoxic, and antimicrobial 81 
activities of hydroethanolic, infused and decocted extracts prepared with the three M. oleifera 82 
organs were assessed in vitro using different cellular assays and food-borne microorganisms. 83 
In this way, it is intended to demonstrate and validate the food and medicinal potential of M. 84 
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oleifera, which can have a direct impact on the food security of local African populations and 85 
be useful for the development of new functional foods and nutraceuticals. 86 
 87 
2. Material and methods 88 
2.1. Sampling and samples preparation 89 
M. oleifera seeds, flowers and immature fruits (Fig. 1) were collected in early May 2019 in two 90 
locations in Guinea-Bissau: Granja (11º 52’02’’N; 15º 36’06’’W), a state farm inside Bissau 91 
urban area, and in a homegarden in Ponta Romana, Quinhamel, located in the countryside 92 
(11º54’18’’N; 15º49’45’’W). The two collecting sites are about 30 km apart and the soil and 93 
climatic conditions in both sites are similar (ferralsols, rainfall c. 1500 mm per year). The main 94 
differences are the urban vs. rural environment and the fact that in Granja the harvested trees 95 
were isolated, with direct sunlight during most of the day and in Ponta Romana the samples 96 
were taken from trees of a living fence in a homegarden, with less direct sunlight. The plant 97 
samples were then lyophilized (FreeZone 4.5, Labconco, MO, USA) and reduced to a fine 98 
powder that was stored in well-sealed plastic bags at -20 ºC in the dark until further analysis. 99 
 100 
2.2. Nutritional value and energy assessment 101 
The M. oleifera edible samples were analysed for moisture, protein, fat, and ash contents 102 
following the AOAC analytical procedures (AOAC International, 2016). Total carbohydrates 103 
were calculated by difference and the energetic value was calculated according to the 104 
Regulation (EC) No. 1169/2011 of The European Parliament and of the Council as follows: 105 





2.3. Chromatographic analysis of free sugars, organic acids, fatty acids, and tocopherols 110 
Free sugars were analysed in a high-performance liquid chromatography (HPLC) system 111 
(Knauer, Smartline system 1000, Berlin, Germany) coupled to a refractive index detector 112 
(Smartline System 1000), using the internal standard (melezitose, Sigma-Aldrich, St Louis, 113 
MO, USA) method previously described by Spréa et al. (2020). Data were recorded and 114 
processed using Clarity 2.4 software (DataApex, Prague, Czech Republic) and the results were 115 
expressed as g per 100 g dw. 116 
Organic acids were analysed by ultra-fast liquid chromatography (Shimadzu 20A series, 117 
Shimadzu Corporation, Kyoto, Japan) coupled to a diode-array detector operating in the 118 
conditions described by Spréa et al. (2020). The compounds were identified by comparing their 119 
retention time and UV-Vis spectra with those of standards (oxalic, malic, ascorbic, citric, and 120 
fumaric acids, Sigma-Aldrich, St. Louis MO, USA) and quantified based on calibration curves 121 
obtained by plotting the peak area recorded at 245 nm for ascorbic acid and at 215 nm for the 122 
remaining acids against concentration. Data were recorded and processed using LabSolutions 123 
Multi LC-Photodiode Array (PDA) software (Shimadzu Corporation, Kyoto, Japan) and the 124 
results were given as g per 100 g dw. 125 
The fatty acids profile was determined by gas-liquid chromatography (DANI 1000, 126 
Switzerland) coupled to a flame ionization detector (FID) operating in the conditions previously 127 
described by Spréa et al. (2020). Data were recorded and processed using Clarity 4.0 software 128 
and the results were given as relative percentage of each fatty acid. 129 
Tocopherols were determined using the internal standard (tocol, Matreya, Pleasant Gap, PA, 130 
USA) method and the HPLC system (Smartline System 1000, Knauer, Berlin, Germany) 131 
coupled to a fluorescence detector (FP-2020, Jasco, Easton, USA) programmed for excitation 132 
at 290 nm and emission at 330 nm, as previously described by Spréa et al. (2020). Data were 133 
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recorded and processed using Clarity 2.4 software and the results were given as mg per 100 g 134 
dw. 135 
 136 
2.4. Preparation of M. oleifera hydroethanolic and aqueous extracts 137 
The M. oleifera seed, flower and immature fruit samples were prepared in hydroethanolic, 138 
infused and decocted extracts to evaluate their composition in phenolic compounds and the in 139 
vitro bioactive properties. These preparation/extraction methods were selected according to the 140 
traditional uses of the different parts of the plant (Dhakar et al., 2011; Ilyas et al., 2015; Lim, 141 
2014). 142 
To prepare the hydroethanolic extracts, each sample (2 g) was mixed with ethanol/water 143 
solution (80:20, v/v; 30 mL) and stirred for 1 h at room temperature. After filtering the 144 
supernatant through Whatman filter paper No 4, the residue was re-extracted and the combined 145 
filtrates were concentrated under reduced pressure (rotary evaporator Büchi R-210, 146 
Switzerland) at 40 °C and the aqueous phase was subsequently lyophilized (Iyda et al., 2019). 147 
For decoctions, each sample (2 g) was boiled with distilled water (100 mL) for 5 min in heating 148 
plate (VELP Scientific) and then filtrated through Whatman filter paper No 4. The obtained 149 
decoctions were frozen and lyophilized (Iyda et al., 2019). 150 
Only seeds and flowers were used to prepare infusions. The samples (2 g) were infused with 151 
freshly boiled distilled water (100 mL), left aside for 5 min and subsequently filtered through 152 
Whatman filter paper No 4. The resulting extracts were frozen and lyophilized (Adouni et al., 153 
2018). 154 
 155 
2.5. HPLC-DAD-ESI/MSn analysis of phenolic compounds 156 
Phenolic compounds were analysed in hydroethanolic, infused and decocted extracts, which 157 
were redissolved in ethanol/water (80:20, v/v) and water, respectively, to a final concentration 158 
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of 10 mg/mL and filtered using 0.22 μm disposable filter disks. The analysis was performed in 159 
a HPLC system (Dionex Ultimate 3000 UPLC, Thermo Scientific, San Jose, California, USA) 160 
coupled with a diode-array detector (DAD, using 280 and 370 nm as preferred wavelengths) 161 
and a Linear Ion Trap (LTQ XL) mass spectrometer (MS, Thermo Finnigan, San Jose, CA, 162 
USA) equipped with an electrospray ionization (ESI) source. Separation was made in a Waters 163 
Spherisorb S3 ODS-2 C18 column (3 µm, 4.6 mm × 150 mm; Waters, Milford, MA, USA). 164 
The operating conditions were previously described by Bessada, Barreira, Barros, Ferreira, and 165 
Oliveira (2016), as well as the identification and quantification procedures. The results were 166 
given as mg per g of extract. 167 
 168 
2.6. Evaluation of bioactive properties in vitro 169 
2.6.1. Antioxidant activity 170 
Two cell-based assays were performed to measure the in vitro antioxidant activity of the 171 
extracts (0.1563–5 mg/mL), following methodologies formerly described by Spréa et al. (2020) 172 
and Lockowandt et al. (2019). The extracts capacity to inhibit the formation of thiobarbituric 173 
acid reactive substances (TBARS) was assessed using porcine brain cell tissues as oxidizable 174 
substrates, and the results were expressed as half maximal effective extract concentration (EC50) 175 
values (mg/mL). The oxidative haemolysis inhibition assay (OxHLIA) was performed to assess 176 
the extracts capacity to protect sheep erythrocytes from the AAPH (2,2′-azobis(2-177 
methylpropionamidine) dihydrochloride)-induced oxidative haemolysis. Half maximal 178 
inhibitory concentration (IC50) values (μg/mL) were calculated for time intervals (Δt) of 60 and 179 
120 min and translate the extract concentration required to keep 50% of the erythrocyte 180 
population intact for 60 and 120 min. Trolox (Sigma-Aldrich, St. Louis, MO, USA) was used 181 
as a positive control. 182 
 183 
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2.6.2. Nitric oxide (NO)-production inhibition activity 184 
The anti-inflammatory activity of the extracts (at concentrations up to 400 μg/mL) was assessed 185 
based on the nitric oxide (NO) production by a lipopolysaccharide (LPS)-stimulated murine 186 
macrophage (RAW 264.7) cell line. The NO production was quantified based on the nitrite 187 
concentration using the Griess Reagent System kit containing sulphanilamide, N-1-188 
naphthylethylenediamine dihydrochloride and nitrite solutions, following a procedure 189 
previously described by Corrêa et al. (2015). Dexamethasone (Sigma-Aldrich, St. Louis, MO, 190 
USA) was used as a positive control, while no LPS was added in negative controls. The effect 191 
of the tested extracts in NO basal levels was also assessed by performing the assay in the 192 
absence of LPS. The results were expressed as IC50 values (μg/mL), which correspond to the 193 
extract concentration providing 50% of NO production inhibition. 194 
 195 
2.6.3. Cytotoxic activity 196 
The extracts cytotoxicity was assessed by the sulforhodamine B (Sigma-Aldrich, St. Louis, 197 
MO, USA) assay against four human tumour cell lines (acquired from Leibniz-Institut DSMZ), 198 
namely MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer), HeLa 199 
(cervical carcinoma), and HepG2 (hepatocellular carcinoma), following a protocol previously 200 
described by Spréa et al. (2020). Ellipticine (Sigma- Aldrich, St. Louis, MO, USA) was used 201 
as a positive control. The same assay was also used to evaluate the hepatotoxicity of the extracts 202 
against a non-tumour cell line (PLP2, porcine liver primary cells) obtained as described by 203 
Spréa et al. (2020). The extract concentration (μg/mL) causing 50% cell growth inhibition 204 





2.6.4. Antimicrobial activity 209 
The extracts were redissolved in 5% dimethyl sulfoxide (DMSO) to a concentration of 10 210 
mg/mL and further diluted. The microdilution method (Soković et al., 2010) was performed to 211 
assess the antimicrobial activity against the Gram-negative bacteria Escherichia coli (ATCC 212 
35210), Salmonella Typhimurium (ATCC 13311) and Enterobacter cloacae (ATCC 35030), 213 
and the Gram-positive Staphylococcus aureus (ATCC 6538), Bacillus cereus (clinical isolate) 214 
and Listeria monocytogenes (NCTC 7973). The antifungal activity was assessed against 215 
Aspergillus fumigatus (ATCC 1022), Aspergillus ochraceus (ATCC 12066), Aspergillus niger 216 
(ATCC 6275), Penicillium funiculosum (ATCC 36839), Penicillium ochrochloron (ATCC 217 
9112), and Penicillium aurantiogriseum (food isolate) (Corrêa et al., 2015). The minimum 218 
extract concentrations that completely inhibited bacterial growth (MICs) were determined by a 219 
colorimetric microbial viability assay, and minimum bactericidal concentration (MBC) and 220 
minimum fungicidal concentration (MFC) were also calculated. Streptomycin, ampicillin, 221 
ketoconazole and bifonazole (Sigma-Aldrich, St. Louis, MO, USA) were used as positive 222 
controls, and 5% DMSO was used as a negative control. 223 
 224 
2.7. Statistical analysis 225 
Three samples were used for each analysis and all the assays were carried out in triplicate. The 226 
results were presented as mean values and standard deviation. A Student’s t-test was applied to 227 
assess significant difference among plant samples with a different geographic origin 228 
(Quinhamel and Bissau), with α = 0.05. In the bioactive assays, a one-way analysis of variance 229 
(ANOVA) was applied, followed by Tukey’s HSD test, with α = 0.05, to assess significant 230 
differences between hydroethanolic, infused and decocted extracts. The analysis was carried 231 
out using SPSS v. 22.0 program SPSS Statistics software (IBM Corp., Armonk, NY, USA). 232 
 233 
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3. Results and discussion 234 
3.1. Nutritional composition of M. oleifera edible parts 235 
Since the plants composition is affected by different factors, such as the edaphoclimatic 236 
conditions of the different growing sites, agricultural practices, harvesting period, and genetic 237 
characteristics, among others (Iyda, Fernandes, Calhelha, et al., 2019), the studied samples of 238 
M. oleifera were collected at two distinct locations in Guinea-Bissau. Table 1 presents the 239 
proximal composition of the M. oleifera seeds, flowers, and fruits collected in Quinhamel and 240 
Bissau. Carbohydrates were found to be major constituents in all studied samples; the highest 241 
levels were detected in the fruit (71.91±0.04 and 79.6±0.1 g/100 g dw) and the lowest in the 242 
seeds (38.85±0.03 and 41.2±0.3 g/100 g dw in samples from Bissau and Quinhamel, 243 
respectively). Proteins rank second with the seeds showing the higher levels (30.0±0.6 – 244 
31.88±0.08 g/100 g dw), followed by the flower and the fruit. These last two plant parts also 245 
had an interesting content of ash (total minerals), which ranged from 19.83±0.01 to 21.3±0.4 246 
g/100 g dw. As expected, the seeds had a higher fat content (~26.3 g/100 g dw) than the other 247 
two edible parts of M. oleifera. In addition, fruits collected in Quinhamel stood out with a 248 
significantly higher fat content (4.3±0.1 g/100 g dw) than those collected in Bissau (2.67±0.06 249 
g/100 g dw). The results obtained in this study are slightly lower than those previously reported 250 
by Gopalakrishnan, Doriya, and Kumar (2016) and Liang, Wang, Li, Chu, and Sun (2019) for 251 
the fat (38.67 and 39.12 g/100 g) and protein (35.97 and 40.34 g/100 g) contents in Indian M. 252 
oleifera seeds, but were higher for carbohydrates (8.67 and 8.94 g/100 g). 253 
Regarding the energy contribution, 100 g fruit and flower portions provide comparable values 254 
(~390–396 kcal), while that of seeds were higher (~518–522 kcal) mainly due to the fat content. 255 
According to previous reports, M. oleifera oil can accelerate wound healing (Liang et al., 2019) 256 
and the seed protein fraction has potential to be used in surface water purification due to 257 
coagulant effects (Baptista et al., 2017). Therefore, M. oleifera edible parts arise as interesting 258 
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possibilities for being exploited as raw materials for production of vegetable oil, protein-rich 259 
foods and skincare products. 260 
As shown in Table 1, the chromatographic analysis allowed to detect and quantify four free 261 
sugars in the studied M. oleifera flowers and fruits, namely fructose, glucose, sucrose and 262 
trehalose, while just glucose and fructose were found in the seeds. The highest levels were 263 
quantified in the fruits (16.7±0.1 – 18.8±0.2 g/100 g fw), followed by the flowers (11.1±0.1 –264 
12.0±0.2 g/100 g fw) (Fig. S1, supplementary material) and lastly by the seeds with 265 
significantly lower levels (1.32±0.09 – 1.86±0.06 g/100 g fw). It was also noted that the 266 
quantitative sugar profile of the fruit and flower samples seemed to have been affected by their 267 
different origin. These differences could be attributed to edaphoclimatic factors and some biotic 268 
conditions that can affect biochemical and physiological processes involved in the plant sugars’ 269 
production (Ziani et al., 2019). In a previous study, Ziani et al. (2019) identified fructose, 270 
glucose and sucrose in M. oleifera leaves from Algeria and reported a total free sugars content 271 
of 3.82 g/100g dw. Upadhyay, Yadav, Mishra, Sharma, and Purohit (2015) described L-272 
arabinose, D-galactose, D-glucuronic acid, L-rhamnose, D-mannose, and D-xylose as the 273 
predominant sugars in the purified whole-gum exudates of M. oleifera. 274 
Regarding organic acids, the analysis allowed identifying oxalic, malic, ascorbic, citric, and 275 
fumaric acids in flower and fruit samples from both locations (Table 1). Citric and malic acids 276 
were the major compounds, while just traces of fumaric acid were detected. Fruits collected in 277 
Bissau contained a higher level of ascorbic acid (0.65±0.02 g/100 g fw) than those from 278 
Quinhamel or the flower samples. The total organic acid contents ranged from 4.71±0.02 – 279 
5.75±0.02 g/100 g fw in fruits to 5.85±0.01 – 6.42±0.01 g/100 g fw in flowers. In M. oleifera 280 
seeds, ~10.5 g/100 g fw of oxalic acid were quantified (Table 1), about twice the total content 281 
of organic acids found in the other two parts of the plant. Traces of fumaric acid were also 282 
detected. It is known that plant foods with a high oxalic acid concentration should be consumed 283 
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moderately, because the high intake of oxalates may promote the formation of kidney stones, 284 
irritation of the intestinal mucosa, and also interferes with calcium absorption (Iyda, Fernandes, 285 
Ferreira, et al., 2019). To the best of the authors’ knowledge, no data are available in the 286 
literature regarding the organic acid composition of M. oleifera seeds, flowers or fruits. In 287 
leaves, Ziani et al. (2019) already reported oxalic, malic and ascorbic acids. 288 
The main fatty acids identified in the studied M. oleifera edible parts are also presented in Table 289 
1, while the detailed profiles are shown in Table S1 provided in Supplementary Material. 290 
Twenty-one fatty acids were identified in the fruit and flower lipid fractions, while just 14 were 291 
detected in the seed samples. The flower lipid fraction was mainly composed by unsaturated 292 
fatty acid (SFA; ~41%, due to the contribution of C16:0, C22:0 and C18:0), followed by 293 
polyunsaturated fatty acids (PUFA; 32.4±0.2 – 37.9±0.1 %), namely α-linolenic (C18:3n3) and 294 
linoleic (C18:2n6) acids. M. oleifera fruits were abundant in monounsaturated fatty acids 295 
(MUFA; 49.0±0.1 – 55.0±0.6 %), particularly those collected in Quinhamel homegardens, due 296 
to the high contents of oleic acid (C18:1n9), followed by SFA (31.3±0.2– 33.4±0.5 %), which 297 
predominated in the fruit samples from Bissau, given the high levels of palmitic (C16:0), 298 
behenic (C22:0) and stearic (C18:0) acids. MUFA also predominated in the seed samples 299 
(73.1±0.5 – 75.1±0.2 %), mostly C18:1n9 but also minor levels of eicosenoic (C20:1) and 300 
palmitoleic (C16:1) acids. The SFA C16:0 and C22:0 were also detected in this plant part. In a 301 
previous work, Zheng et al. (2019) studied the effects of soil drenching and foliar spraying of 302 
boron on M. oleifera seed oil quality and reported C18:1 levels ranging from 64.24 to 71.17%, 303 
a result comparable to that obtained in the present study (69.44±0.4 and 71.6±0.2% for seeds 304 
from Bissau and Quinhamel, respectively). The lipid composition of M. oleifera seeds is greater 305 
than that of soybean, which makes it nutritionally important and the refined seed oil is 306 
acceptable to substitute the olive oil because of the presence of all the essential fatty acids in it 307 
(Singh et al., 2019). 308 
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The tocopherols composition of the studied M. oleifera edible parts is shown in Table 1, where 309 
it can be seen that α-tocopherol was the prevalent isoform in all samples, followed by δ-310 
tocopherol. The flower samples showed the highest α-tocopherol concentrations, ranging from 311 
17.22±0.09 to 18.90±0.01 mg/100 g dw (HPLC profile in Fig. S2, supplementary material). 312 
Fruit and seed samples revealed a total content of tocopherols ranging from 2.71±0.01 to 313 
4.86±0.03 g/100 g dw and the samples collected in Bissau showed higher levels of these 314 
lipophilic antioxidants. Singh et al. (2020) reported that tocopherols together with ascorbic acid, 315 
carotenoids and flavonoids are antioxidants found in M. oleifera with the ability to eliminate 316 
reactive oxygen species. 317 
 318 
3.2. Polyphenols compositions of M. oleifera hydroethanolic and aqueous extracts 319 
Data on the chromatographic characteristics (retention time, UV-Vis spectra in the maximum 320 
absorption, molecular ion, and main MS2 fragments) and tentative identification of the phenolic 321 
compounds found in the hydroethanolic, infused and decocted extracts of M. oleifera are 322 
described in Table 2. Twenty-four phenolic compounds were found, being 19 glycosylated 323 
flavonol derivatives, 3 phenolic acids, and 2 flavan-3-ols. The phenolic composition of M. 324 
oleifera has been extensively studied by other authors (Makita et al., 2016; Nouman et al., 2016; 325 
Ramabulana et al., 2016; Ziani et al., 2019); however, there are many compounds identified in 326 
the present work that, to the best of the author’s knowledge, have never been previously 327 
identified in M. oleifera. Peaks 3, 6, 13, 14, 15, 18, 20, 21, and 22 were identified as (+)-328 
catechin, (-)-epicatechin, quercetin-3-O-rutinoside, apigenin-6-C-glucoside, quercetin-3-O-329 
glucoside, kaempferol-3-O-rutinoside, isorhamnetin-3-O-rutinoside, kampferol-3-O-glucoside, 330 
and isorhamnetin-3-O-glucoside, respectively, by comparing their retention time, UV-Vis 331 
spectra, and mass fragmentation patterns with those of the available commercial standards. 332 
Only three phenolic acids were tentatively identified, peaks 1/2 ([M-H]- at m/z 337) and 4 ([M-333 
15 
H]- at m/z 367), as cis/trans 3-O-p-coumaroylquinic acid and 3-O-feruloyquinic acid, 334 
respectively. Peak 1 presented a base peak at m/z 191 (quinic acid) along with a peak at m/z 163 335 
(corresponding to the p-coumaroyl acid moiety); peak 2 presented the same chromatographic 336 
behaviour, leading to the respective identification of the cis and trans isomers of p-337 
coumaroylquinic acid. These peaks (1/2 and 4) have been previously identified in the foliar 338 
parts of M. oleifera from South Africa, after being exposed to certain levels of radiation 339 
(Ramabulana et al., 2016). 340 
The flavonoid was, without any doubt, the most abundant group of phenolic compounds 341 
identified in studied M. oleifera samples, with glycosylated derivatives of quercetin having a 342 
superior numerical expression to any other identified flavonoid aglycone. Peaks 10 ([M-H]- at 343 
m/z 625), 16 ([M-H]- at m/z 505), and 17/19 ([M-H]- at m/z 549), tentatively identified as 344 
quercetin-O-dihexoside, quercetin-O-acetylhexoside and quercetin-malonylhexoside, 345 
respectively, have been previously identified in the leaves of M. oleifera from South Africa 346 
(Ramabulana et al., 2016), Pakistan (Nouman et al., 2016), and Namibia (Makita et al., 2016). 347 
Peak 5 presented a pseudomolecular ion [M-H]- at m/z 711, and MS2 fragments at m/z 667 (loss 348 
of 44 u, carboxyl radical), m/z 505 (loss of sinapoylradical), m/z 463 (loss of sinapoyl and acetyl 349 
radicals), and m/z 301 (quercetin aglycone), which allowed the tentative identification as 350 
quercetin-acetylglucoside-sinapic acid. This peak has not been identified in M. oleifera 351 
samples, so its tentative identification was performed following the previously described by 352 
Medina et al. (2017) in Passiflora edulis shell, without numbering the oxygen atoms and 353 
radicals position since it was not possible to compare the abundance of each fragment. Peak 11, 354 
also a glycosylated derivative of quercetin, presented a pseudomolecular ion [M-H]- at m/z 595, 355 
and MS2 fragments at m/z 463 and m/z 301, corresponding to the loss of a pentosyl and hexosyl 356 
moieties, respectively. As peak 5, peak 11 was not previously identified in M. oleifera samples, 357 
so its tentative identification followed the previously described by Barros et al. (2013) in Cistus 358 
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ladanifer. The second major flavonoid group was that of C-glycosylated apigenin derivatives, 359 
represented by peaks 7 ([M-H]- at m/z 593), 9 ([M-H]- at m/z 593) and 12 ([M-H]- at m/z 431), 360 
tentatively identified as apigenin-6,8-C-diglucoside, apigenin‐O‐hexoside‐C‐hexoside, and 361 
apigenin-C-hexoside, respectively, following the previously described by Truchado et al. 362 
(2011) and Qiao et al. (2011), being previously identified similar compounds in M. oleifera 363 
leaves (Nouman et al., 2016; Ramabulana et al., 2016). Kaempferol derivatives were also found; 364 
peak 8, tentatively identified as kaempferol-O-malonylhexoside, was previously reported in M. 365 
oleifera leaf samples by Makita et al. (2016), and peak 23, presenting a pseudomolecular ion 366 
[M-H]- at m/z 695, was tentatively identified as kaempferol-O-malonyldihexoside, following 367 
the previously described by Sánchez-Salcedo et al. (2016) in Morus spp. leaves (to the best of 368 
the authors’ knowledge, this peak as not been described previously in M. oleifera). Finally, 369 
peak 24, tentatively identified as isorhamnetin-O-malonylhexoside, was previously described 370 
in M. oleifera leaves by Ziani et al. (2019).  371 
Data on the quantification of the phenolic compounds present in M. oleifera edible parts are 372 
presented in Table 3. The profile of phenolic compounds present in each group of M. oleifera 373 
samples was very different, quantitatively but also qualitatively, with very few similar 374 
compounds between samples, which could be explained by the different physiological function 375 
of the studied plant parts and/or different microenvironmental conditions in each sampling site, 376 
namely a wetter and more shaded environment at the Ponta Romana homegarden. 377 
The hydroethanolic extracts prepared with flowers from Bissau presented the highest total 378 
concentration of phenolic compounds, 14.7±0.1 mg/g of extract, followed by the Quinhamel 379 
flower hydroethanolic extract, with 13.8±0.1 mg/g of extract. The seed samples were the only 380 
ones presenting flavan-3-ols derivatives, representing the major group of phenolics within this 381 
group. Another information that is important to highlight is the fact that the decoction prepared 382 
with the Quinhamel fruit sample had no phenolic compounds. Although an aqueous preparation 383 
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such as decoction can lead to the thermal degradation of compounds, the absence of compounds 384 
may be related to the sample itself, since the hydroethanolic extract of this sample also had the 385 
lowest total concentration of phenolic compounds (0.765±0.001 mg/g extract) within the 386 
corresponding group of samples. 387 
Despite the very different phenolic profile, the most abundant phenolic compound (apart from 388 
seeds samples) was peak 1 (cis 3-O-p-coumaroylquinic acid), which did not produce an effect 389 
of higher concentration of phenolic acids, since it was the group of flavonoids that stood out 390 
(less in the Quinhamel flower hydroethanolic extract). These results are in accordance with the 391 
described by Ziani et al. (2019) and Nouman et al. (2016) in M. oleifera leaves, in which they 392 
revealed total concentrations of flavonoids of up to 30 mg/g extract and 2.98 mg/g extract, 393 
respectively. 394 
 395 
3.3. Bioactive properties of M. oleifera hydroethanolic and aqueous extracts 396 
To evaluate the bioactive properties of the different M. oleifera edible parts, hydroethanolic, 397 
infused and decocted extracts were prepared according to traditional uses and applications. 398 
Fruits are traditionally prepared as a culinary vegetable, stewed in curries and soups. In India 399 
and Bangladesh, fruits are usually prepared by boiling pods to the desired level of tenderness 400 
in a mixture of coconut milk and spices (Lim, 2014). Therefore, only hydroethanolic and 401 
decocted extracts were prepared in this study with the fruit samples. On the other hand, seeds 402 
and flowers were used to prepare hydroethanolic, infused and decocted extracts. Traditionally, 403 
mature seeds are fried and eaten like peanuts in Nigeria and added to sauces for their bitter taste. 404 
In Pakistan are used to prepare M. oleifera seed tea infusions (Ilyas et al., 2015) and in India 405 
seed decoctions (Dhakar et al., 2011). The flowers are cooked and consumed either mixed with 406 
other foods or fried in batter, butter or oil. In West Bengal and Bangladesh, these are usually 407 
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cooked with green peas and potato, while in Africa are eaten as a vegetable, added to sauces or 408 
used to make infusions (Lim, 2014). 409 
 410 
3.3.1. Antioxidant activity 411 
Two in vitro cell-based assays were used to measure the antioxidant activity of the 412 
hydroethanolic, infused and decocted extracts of the different M. oleifera parts (Table 4). These 413 
assays evaluate the extract ability to inhibit the formation of thiobarbituric acid reactive 414 
substances (TBARS) and the oxidative haemolysis (OxHLIA) using porcine brain tissues and 415 
erythrocytes as oxidizable biological substrates, respectively. As can be observed in Table 4, 416 
in the TBARS assay, significant differences were found between the three plant parts and 417 
between the extraction methods. The hydroethanolic extracts showed the lowest EC50 values, 418 
thus translating a greater capacity to inhibit the TBARS formation than the aqueous extracts. 419 
This result could be justified by the greater efficiency of the hydroethanolic mixture in 420 
extracting phenolic compounds and other antioxidants (Padayachee & Baijnath, 2019). In the 421 
OxHLIA assay, the sheep erythrocytes were subjected to the haemolytic action of both 422 
hydrophilic and lipophilic radicals generated in in vitro by the thermal decomposition of the 423 
free-radical initiator AAPH and as a consequence of the initial attack, respectively. By 424 
observing the data presented in Table 4, it can be noticed that infusions prepared with seed and 425 
flower samples from Bissau showed the best results, with IC50 values lower than those of the 426 
trolox, the water-soluble analog of vitamin E used as a positive control. Interestingly, the 427 
hydroethanolic extracts did not show any antihemolytic effect. In a previous study, Pakade, 428 
Cukrowska, and Chimuka (2013) compared the antioxidant activity of M. oleifera leaves and 429 
flowers to that of several vegetables from South Africa, including spinach, cauliflower, 430 
broccoli, cabbage, and peas, and reported a total flavonoid content in M. oleifera three times 431 
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higher than that quantified in the others plant foods, thus concluded that M. oleifera is a better 432 
source of antioxidants. 433 
 434 
3.3.2. NO-production inhibition activity 435 
The NO-production inhibition (or anti-inflammatory) activity of the tested M. oleifera extracts 436 
was assessed based on the NO-production inhibition activity and the results are presented in 437 
Table 4. The extracts prepared with the seed samples from both locations were able to reduce 438 
the production of NO by LPS-stimulated murine macrophages. This result followed the same 439 
trend observed for the TBARS formation inhibition assay, with the hydroethanolic preparations 440 
showing the best results. However, flower and fruit extracts did not reveal anti-inflammatory 441 
activity at the tested concentrations. In previous studies, Minaiyan, Asghari, Taheri, Saeidi, and 442 
Nasr-Esfahani (2014) showed that hydroalcoholic seed extracts are effective in the treatment of 443 
experimental colitis and associated this effect with the major bioactive biophenols and 444 
flavonoids (Minaiyan et al., 2014). In turn, Jaja-Chimedza et al. (2017) connected the anti-445 
inflammatory and antioxidant properties of M. oleifera seeds to the presence of isothiocyanates. 446 
Accordingly Padayachee and Baijnath (2020), infusions of M. oleifera leaves, seeds, flowers, 447 
roots, and bark display anti-inflammatory activity. Alhakmani, Kumar, and Khan (2013) also 448 
attributed anti-inflammatory effects to the M. oleifera flower extract, which supports the 449 
traditional use of this preparation in Oman and other Asian countries.  450 
 451 
3.3.3. Cytotoxicity to tumour and non-tumour cells 452 
Considering the described uses of the different parts of M. oleifera in traditional medicine, the 453 
prepared extracts were also tested for their cytotoxicity for tumour and non-tumour cell lines. 454 
The performed sulforhodamine B assay allows to evaluate the effect of the extracts on cell 455 
proliferation (Ziani et al., 2019). Therefore, GI50 values translate the extract concentration 456 
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providing 50% of cell growth inhibition. As presented in Table 4, the hydroethanolic extracts 457 
of seed and flower samples originated the lower GI50 values, thus translating a higher activity 458 
than the aqueous extracts against HeLa (cervical), HepG2 (hepatocellular), MCF-7 (breast) and 459 
NCI-H460 (lung) tumour cells. Among the hydroethanolic extracts, those prepared with seeds 460 
were more effective against the HepG2 cell line, regardless of the geographic origin of the 461 
samples (with GI50 of 82±5 – 95±2 µg/mL), while those prepared with flowers were more 462 
cytotoxic to breast MCF-7 cells (with GI50 of 163±5 – 187±10 µg/mL). For seeds, the 463 
decoctions proved to be the least cytotoxic preparations for the tested cell lines (given the higher 464 
GI50 values), which is in line with the results obtained with the OxHLIA assay (where they also 465 
had the highest IC50 values). The aqueous flower extracts were not cytotoxic at the tested 466 
concentrations, nor any of those prepared with the fruits. 467 
In previous studies, Jung (2014) found that aqueous M. oleifera leaf extracts are able to reduce 468 
the proliferation and invasion of cancer cells by inducing apoptosis, inhibiting the tumour cell 469 
growth and decreasing the level of internal reactive oxygen species in human lung cancer cells. 470 
Al-Asmari and co-workers (2015) evaluated the anticancer properties of M. oleifera leaf, bark 471 
and seed extracts against breast (MDA-MB-231) and colorectal (HCT-8) cancer cells and 472 
obtained remarkable anticancer activities with the leaf and bark extracts, while the seed extract 473 
showed less activity. It has also been reported that the flavonoids quercetin and kaempferol 474 
present in M. oleifera extracts may act as potential chemopreventive agents, being able to 475 
reduce the proliferation of human carcinoma through the induction of in vitro apoptosis 476 
(Padayachee & Baijnath, 2019). In addition, the presence of these and other antioxidants in M. 477 
oleifera allows to reduce oxidative stress and, consequently, help prevent the development of 478 
cancer. Among the metabolites with antioxidant activity found in M. oleifera are flavonoids, 479 
phenolic acids, saponins, tannins, β-carotene, and terpenoids (Singh et al., 2019). 480 
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Table 4 also shows that, with the exception of the hydroethanolic seed extracts, no other extract 481 
was cytotoxic to the non-tumour PLP2 cells at the tested concentrations. This toxicity of the 482 
hydroethanolic seed extracts to porcine liver primary cells may somehow justify the absence of 483 
antihemolytic activity in the OxHLIA assay, since the erythrocytes may have been rapidly lysed 484 
due to the cytotoxic effect of these hydroalcoholic preparations. 485 
In many countries, M. oleifera seed powder is used to purify water on aquaculture farms due to 486 
its coagulation properties. Nevertheless, the application of a large amount of this ingredient in 487 
aquaculture ponds leads to fish mortality due to the presence of toxic or antinutritional 488 
compounds. The seed powder toxicity has already been observed in guppies (Poecilia 489 
reticulata), Nile tilapia (Oreochromis niloticus), protozoa (Tetrahymena pyriformis), and 490 
bacteria (Escherichia coli) (Kavitha et al., 2012). Regarding ethanolic and aqueous extracts of 491 
both M. oleifera fruits and leaves, Luqman, Srivastava, Kumar, Maurya, and Chanda (2011) 492 
showed that these are well tolerated by experimental animals without toxicity of the extracts up 493 
to a dose of 100 mg/kg of body weight. The aqueous and hydroethanolic extracts of M. oleifera 494 
flowers have also been described as having a significant hepatoprotective effect, which may be 495 
due to the presence of quercetin, a well-known flavonoid with hepatoprotective activity 496 
(Upadhyay et al., 2015). Furthermore, Singh et al. (2020) described that alcoholic and aqueous 497 
extracts from flowers and roots of M. oleifera act as hepatoprotectors against the effect of 498 
acetaminophen (a drug used to treat pain and fever) by decreasing the level of serum enzymatic 499 
markers and bilirubin levels. 500 
 501 
3.3.4. Antimicrobial activity 502 
The results of the antimicrobial activity of M. oleifera extracts are presented in Table 5. All the 503 
extracts had significant antimicrobial effects against the tested bacteria and fungi. The MIC and 504 
MBC values obtained for Bacillus cereus, Staphylococcus aureus, Listeria monocytogenes, and 505 
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Escherichia coli, as well as for Enterobacter cloacae and Salmonella Typhimurium, were 506 
comparable to those of streptomycin and ampicillin, the antibiotics used as positive controls, 507 
thus translating a similar bacteriostatic and bactericidal activity. In general, decoctions were the 508 
most effective preparations against the tested bacteria and, in the case of seeds, it is also worth 509 
noting the higher activity of the hydroethanolic and infused extracts prepared with seeds from 510 
Quinhamel and the decocted extracts made with seed from Bissau. The antimicrobial activity 511 
of M. oleifera leaf, root, bark and seed extracts against bacteria, yeasts, dermatophytes, and 512 
helminths pathogenic to human was previously investigated by Upadhyay, Yadav, Mishra, 513 
Sharma, and Purohit (2015), which verified that the seed aqueous extract inhibits the growth of 514 
Pseudomonas aeruginosa and S. aureus. According to previous reports, the antimicrobial 515 
activity of M. oleifera seed powder is conferred by a short cationic protein (Singh et al., 2019), 516 
as well as by saponins, tannins, phenolics, and alkaloids (Padayachee & Baijnath, 2019). 517 
The antifungal activity of the tested M. oleifera extracts resulted in MIC and MBC values lower 518 
or similar to those of the positive controls ketoconazole and bifonazole (Table 5). The 519 
antifungal activity of aqueous leaf extracts of M. oleifera was previously confirmed by 520 
Padayachee and Baijnath (2020) against Penicillium spp., while the ethanolic extract also 521 
inhibited Candida albicans, Penicillium spp., and Mucor spp. The phytochemical screening of 522 
this plant part revealed the presence of alkaloids, flavonoids, saponins, terpenoids, steroids, 523 
tannins, and cardiac glycosides, which may act as natural antimicrobials (Padayachee & 524 
Baijnath, 2019; Raj et al., 2011). 525 
 526 
4. Conclusion 527 
The results of the present study highlighted the nutritional quality of M. oleifera fruits, seeds 528 
and flowers from Bissau and Quinhamel and the bioactive potential of their herbal preparations. 529 
These edible and medicinal matrices stood out not only with high nutritional value, but also for 530 
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their potential to be used in food fortification and in the development of new functional foods, 531 
nutraceuticals and pharmaceutical formulations. M. oleifera is a natural resource to be valorised 532 
by underprivileged population facing poverty and malnutrition issues, but also by other 533 
stockholders, specifically in underdeveloped and developing nations that have an insufficient 534 
technical resources. 535 
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Figure captions 681 
Fig. 1. Edible parts of Moringa oleifera characterized in this study: a) flowers; b) 682 
seeds; and c) Immature fruits. 683 
 684 
 685 
Supplementary material captions 686 
Table S1. Detailed fatty acid composition of M. oleifera edible parts. 687 
Fig. S1. Free sugars profile of M. oleifera fruits from Bissau characterized in this study: 688 
1- Mobile phase; 2- Fructose; 3- Glucose; 4- Sucrose; 5- Melezitose (PI). 689 
Fig. S2. Tocopherols profile of M. oleifera flowers from Quinhamel characterized in this 690 
study: 1- Mobile phase; 2- α-Tocopherol; 3- δ-Tocoperol; 4- Tocol (PI). 691 
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Table 1 
Nutritional value and composition in free sugars, organic acids, main fatty acids, and tocopherols of M. oleifera edible parts. 
 Seeds Student's t-test Flowers Student's t-test Fruits Student's t-test 
 Quinhamel Bissau p-value Quinhamel Bissau p-value Quinhamel Bissau p-value 
Moisture (%) np np - 81.4±0.5 81.4±0.1 0.851 79.0±0.4 76.8±0.9 0.006 
Fat (g/100 g) 26.0±0.1 26.6±0.1 0.001 5.27±0.07 5.02±0.05 0.002 4.3±0.1 2.67±0.06 <0.001 
Proteins (g/100 g) 30.0±0.6 31.88±0.08 0.002 21.3±0.4 19.83±0.01 0.001 19.79±0.04 19.49±0.06 0.476 
Ash (g/100 g) 2.8±0.1 2.67±0.01 0.001 7.93±0.09 7.95±0.07 0.346 6.31±0.06 5.93±0.05 <0.001 
Carbohydrates (g/100 g) 41.2±0.3 38.85±0.03 <0.001 65.5±0.3 67.2±0.1 0.001 79.6±0.1 71.91±0.04 <0.001 
Energy (kcal/100 g) 518.3±0.4 522.2±0.5 <0.001 394.6±0.5 393.2±0.1 0.007 396.3±0.5 389.7±0.3 <0.001 
Fructose (g/100 g) nd nd - 2.19±0.02 1.51±0.01 <0.001 3.00±0.04 2.86±0.04 0.003 
Glucose (g/100 g) 0.15±0.05 0.16±0.04 0.651 6.01±0.07 3.30±0.04 <0.001 8.02±0.04 10.03±0.08 <0.001 
Sucrose (g/100 g) 1.17±0.04 1.70±0.03 <0.001 2.93±0.09 5.52±0.07 <0.001 5.03±0.04 4.92±0.01 0.005 
Trehalose (g/100 g) nd nd - 0.82±0.03 0.75±0.01 0.005 0.63±0.01 1.01±0.05 <0.001 
Total sugars (g/100 g) 1.32±0.09 1.86±0.06 <0.001 12.0±0.2 11.1±0.1 0.001 16.7±0.1 18.8±0.2 <0.001 
Oxalic acid (g/100 g) 10.44±0.05 10.6±0.2 0.153 0.77±0.01 1.82±0.01 <0.001 0.66±0.01 1.18±0.01 <0.001 
Malic acid (g/100 g) nd nd - 1.79±0.02 1.29±0.02 <0.001 1.84±0.03 1.30±0.01 <0.001 
Ascorbic acid (g/100 g) nd nd - 0.25±0.01 0.19±0.01 <0.001 0.35±0.01 0.65±0.02 <0.001 
Citric acid (g/100 g) nd nd - 3.05±0.01 3.12±0.02 0.001 1.84±0.02 2.62±0.01 <0.001 
Fumaric acid (g/100 g) tr tr - tr tr - tr tr - 
Total organic acids (g/100 g) 10.44±0.05 10.6±0.2 0.153 5.85±0.01 6.42±0.01 <0.001 4.71±0.02 5.75±0.02 <0.001 
C16:0 6.1±0.2 7.0±0.2 0.002 19.7±0.1 21.6±0.2 <0.001 12.8±0.2 10.4±0.2 <0.001 
C18:0 5.53±0.06 6.5±0.2 <0.001 4.64±0.01 4.23±0.09 <0.001 4.67±0.06 4.73±0.07 0.221 
C18:1n9 71.6±0.2 69.4±0.4 <0.001 25.8±0.1 20.32±0.01 <0.001 52.4±0.6 48.8±0.1 <0.001 
C18:2n6 0.65±0.03 0.69±0.06 0.192 15.1±0.1 14.4±0.5 0.023 7.42±0.08 8.5±0.3 <0.001 
C18:3n3 0.21±0.02 0.195±0.005 0.116 16.4±0.1 22.3±0.3 <0.001 6.67±0.09 6.3±0.4 <0.001 
C22:0 7.0±0.2 6.98±0.09 0.446 5.6±0.2 5.4±0.5 0.414 7.43±0.09 9.1±0.1 <0.001 
C24:0 1.43±0.08 1.33±0.01 0.039 6.0±0.3 5.0±0.3 0.005 1.67±0.09 3.6±0.2 <0.001 
SFA (%) 24.1±0.2 26.0±0.4 0.001 41.0±0.4 40.84±0.08 0.366 31.3±0.2 33.4±0.5 <0.001 
MUFA (%) 75.1±0.2 73.1±0.5 0.001 26.6±0.1 21.23±0.04 <0.001 55.0±0.6 49.0±0.1 <0.001 
PUFA (%) 0.86±0.01 0.89±0.06 0.299 32.4±0.2 37.9±0.1 <0.001 14.4±0.2 17.5±0.6 <0.001 
α-Tocopherol (mg/100 g) 2.22±0.02 3.36±0.01 <0.001 18.90±0.01 17.22±0.09 <0.001 3.13±0.05 4.67±0.02 <0.001 
δ-Tocopherol (mg/100 g) 0.48±0.01 1.48±0.03 <0.001 2.08±0.01 2.68±0.07 <0.001 0.45±0.04 0.19±0.01 <0.001 
Total tocopherols (mg/100 g) 2.71±0.01 4.84±0.01 <0.001 20.98±0.01 19.90±0.01 <0.001 3.58±0.09 4.86±0.03 <0.001 
np - not performed; nd - not detected; tr – traces; C16:0 - palmitic acid; C18:0 - stearic acid; C18:1n9 - oleic acid; C18:2n6 - linoleic acid; C18:3n3 - α-linolenic acid; C22:0 - behenic acid; C24:0 
- lignoceric acid; SFA - saturated fatty acids; MUFA - monounsaturated fatty acids; PUFA - polyunsaturated fatty acids. 
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Table 2 
Phenolic compounds identified in M. oleifera edible parts. It is presented the retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), 
and mass spectral data. 
Peak Rt (min) λmax (nm) [M-H]- (m/z) MS2 (m/z) Tentative identification Reference/method used for quantification 
1 6.19 311 337 191(8), 173(6), 163(100), 153(3), 119(5) cis 3-O-p-Coumaroylquinic acid Ramabulana et al. (2016) 
2 7.09 311 337 191(8), 173(6), 163(100), 153(3), 119(5) trans 3-O-p-Coumaroylquinic acid Ramabulana et al. (2016) 
3 7.11 280 289 245(25), 203(10), 137(31) (+)-Catechin Standard compound 
4 7.16 323 367 193(100), 191(5), 173(5), 149(3), 134(8) 3-O-Feruloyquinic acid Ramabulana et al. (2016) 
5 8.6 256/268/351 711 667(52), 505(100), 463(37), 301(21) Quercetin-O-acetylglucosyl-sinapic acid Medina et al. (2017) 
6 9.57 280 289 245(100), 205(52), 151(29), 137(37) (-)-Epicatechin Standard compound 
7 9.97 322 593 575(11), 503(24), 473(100), 383 (12), 353(27) Apigenin-6,8-C-diglucoside  Truchado et al. (2011)  
8 12.59 342 695 651(53), 489(100), 447(28), 285(41) Kaempferol-O-malonyldihexoside Sánchez-Salcedo et al. (2016) 
9 13.55 337 593 473(35), 431(100), 353(5), 311(62), 283(5) Apigenin‐O‐hexoside‐C‐hexoside Qiao et al. (2011) 
10 15.05 359 625 301(100) Quercetin-O-dihexoside Nouman et al. (2016) 
11 15.98 350 595 463(31), 301(100) Quercetin-O-pentoside-O-hexoside Barros et al. (2013) 
12 16.51 334 431 413(5), 341(6), 311(100) Apigenin-C-hexoside Nouman et al. (2016) 
13 17.77 354 609 301(100) Quercetin-3-O-rutinoside Standard compound 
14 18.35 337 431 413(7), 341(26), 311(100) Apigenin-6-C-glucoside Standard compound 
15 18.91 353 463 301(100) Quercetin-3-O-glucoside Standard compound 
16 20.19 353 505 463(30),301(100) Quercetin-O-acetylhexoside Ramabulana et al. (2016) 
17 20.21 352 549 505(12), 463(22), 301(100) Quercetin-O-malonylhexoside Makita et al. (2016) 
18 21.06 347 593 285(100) Kaempferol-3-O-rutinoside Standard compound 
19 22.06 350 549 505(72), 463(27), 301(100) Quercetin-O-malonylhexoside Makita et al. (2016) 
20 22.07 353 623 315(100) Isorhamnetin-3-O-rutinoside Standard compound 
21 22.39 346 447 285(100) Kampferol-3-O-glucoside Standard compound 
22 23.36 352 477 315(100) Isorhamnetin-3-O-glucoside Standard compound 
23 24.62 346 533 489(89), 447(10), 285(100) Kaempferol-O-malonylhexoside Makita et al. (2016) 




Content (mg/g extract) of the phenolic compounds identified in hydroethanolic, infused and decocted extracts of M. oleifera edible parts. 
Peak 
Seeds Flowers Fruits 
Quinhamel Bissau Quinhamel Bissau Quinhamel Bissau 
HyEth Inf Dec HyEth Inf Dec HyEth Inf Dec HyEth Inf Dec HyEth Dec HyEth Dec 
1 nd nd nd nd nd nd 4.7±0.1a 1.214±0.01e 1.443±0.003d 3.86±0.02b 1.93±0.03c 0.61±0.01f nd nd 0.50±0.01g 0.20±0.01h 
2 nd nd nd nd nd nd 0.39±0.01* nd nd 0.471±0.00* nd nd nd nd nd nd 
3 0.178±0.002a 0.035±0.001c 0.10±0.01b nd nd nd nd nd nd nd nd nd nd nd nd nd 
4 nd nd nd nd nd nd nd nd nd nd nd nd nd nd 0.08±0.01* 0.030±0.003* 
5 nd nd nd nd nd nd 0.23±0.01a 0.092±0.001c 0.14±0.02b 0.020±0.002d 0.02±0.01d tr nd nd nd nd 
6 0.44±0.02a 0.081±0.004d 0.07±0.01e 0.10±0.02c 0.28±0.01b 0.29±0.01b nd nd nd nd nd nd nd nd nd nd 
7 nd nd nd nd nd nd 0.254±0.001c 0.051±0.003f 0.161±0.001d 0.69±0.02a 0.39±0.01b 0.15±0.01e nd nd nd nd 
8 nd nd nd nd nd nd 0.262±0.001a 0.098±0.01c 0.15±0.04b tr nd tr nd nd nd nd 
9 0.08±0.01a 0.024±0.004c 0.072±0.002b nd nd nd nd nd nd nd nd nd nd nd nd nd 
10 nd nd nd nd nd nd tr nd tr tr nd tr nd nd nd nd 
11 nd nd nd nd nd nd 0.061±0.001 nd tr tr nd tr nd nd nd nd 
12 0.05±0.02a 0.008±0.001c 0.010±0.002b nd nd nd nd nd nd nd nd nd nd nd nd nd 
13 nd nd nd nd nd nd 0.239±0.001c 0.2±0.1d 0.136±0.001f 2.44±0.01a 0.55±0.02b 0.19±0.01d nd nd 0.16±0.01e tr 
14 0.041±0.001e 0.050±0.001d 0.003±0.0001f nd nd nd 0.47±0.01a 0.109±0.003c 0.35±0.02b nd nd nd nd nd nd nd 
15 nd nd nd nd nd nd 0.678±0.002a 0.100±0.001g 0.159±0.001d 0.55±0.01b 0.326±0.001c 0.10±0.02g 0.126±0.001f nd 0.20±0.03e nd 
16 nd nd nd nd nd nd nd nd nd nd nd nd 0.156±0.001 nd nd nd 
17 nd nd nd nd nd nd 2.2±0.1b nd nd 3.4±0.1a 0.95±0.01c 0.27±0.01d nd nd nd nd 
18 nd nd nd nd nd nd 0.49±0.02d 0.48±0.01d 1.13±0.03b 1.31±0.01a 0.53±0.02c 0.22±0.01e nd nd 0.18±0.03f nd 
19 nd nd nd nd nd nd 0.75±0.02a 0.184±0.01c 0.71±0.01b 0.10±0.01d 0.073±0.004e 0.020±0.002f nd nd nd nd 
20 nd nd nd nd nd nd nd nd nd nd nd nd nd nd 0.214±0.001 nd 
21 nd nd nd nd nd nd 0.32±0.01b 0.107±0.001d 0.17±0.01c 0.38±0.01a nd nd 0.11±0.01d nd nd nd 
22 nd nd nd nd nd nd 1.3±0.1a 0.093±0.002d 0.14±0.01c 0.247±0.001b nd nd 0.118±0.001c nd nd nd 
23 nd nd nd nd nd nd 0.83±0.01a 0.19±0.01e 0.39±0.01c 0.76±0.01b 0.254±0.003d 0.113±0.004f 0.11±0.01f nd 0.12±0.03f nd 
24 nd nd nd nd nd nd 0.67±0.02a 0.176±0.001e 0.31±0.01c 0.451±0.004b 0.21±0.01d 0.084±0.003g 0.14±0.01f nd 0.20±0.03d nd 
TPA nd nd nd nd nd nd 5.1±0.1a 1.214±0.01e 1.443±0.003d 4.33±0.02b 1.929±0.003c 0.61±0.01f nd nd 0.579±0.002g 0.231±0.003h 
TF3O 0.62±0.02a 0.116±0.001d 0.173±0.001c 0.10±0.02e 0.28±0.01b 0.29±0.01b nd nd nd nd nd nd nd nd nd nd 
TF 0.17±0.01f 0.037±0.001j 0.081±0.002h nd nd nd 8.76±0.03b 1.9±0.1e 3.94±0.04c 10.3±0.1a 3.30±0.04d 1.10±0.02g 0.764±0.001i nd 1.09±0.02g nd 
TPC 0.79±0.02g 0.152±0.002l 0.254±0.003j 0.10±0.02m 0.28±0.01i 0.29±0.01i 13.8±0.1b 3.1±0.1d 5.4±0.1c 14.7±0.1a 5.23±0.04c 1.71±0.03e 0.764±0.001h nd 1.66±0.02f 0.231±0.003k 
nd- not detected; tr- trace amounts; nq – not quantifiable; HyEth – Hydroethanolic extract; Inf - Infusion preparation; Dec- Decoction preparation. TPA- Total Phenolic Acids; TF3O- Total Flavan-3-ol; TF – Total 
Flavonoids; TPC- Total Phenolic Compounds. Standard calibration curves: quercetin-3-O-rutinoside (y = 13343x + 76751, R² = 0.9998, limit of detection (LOD) = 0.18 µg/mL and limit of quantitation (LOQ) = 0.65 
µg/mL, peaks 5, 8, 10, 11, 13, 18, and 20); apigenin-6-C-glucoside (y = 107025x + 61531, R² = 0.9989, LOD = 0.19 µg/mL and LOQ = 0.63 µg/mL, peaks 7, 9, 12, and 14); quercetin-3-O-glucoside (y = 34843x – 
160173, R² = 0.9998, LOD = 0.21 µg/mL and LOQ = 0.71 µg/mL, peaks 15, 16, 17, 19, 21, 22, 23, and 24); ferulic acid (y = 633126x – 185462, R² = 0.999, LOD = 0.20 µg/mL and LOQ = 1.01 µg/mL, peak 4); (+)-
catechin (y = 84950x – 23200, R² = 1, LOD = 0.17 µg/mL and LOQ = 0.68 µg/mL, peaks 3 and 6); and p-coumaric acid (y = 301950x + 6966.7, R² = 0.9999, LOD = 0.68 µg/mL and LOQ = 1.61 µg/mL, peaks 1 and 
2). In each row different letters mean statistically significant differences (p<0.05). *Mean statistical differences obtained by t-Student test.  
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Table 4 
Antioxidant, anti-inflammatory and cytotoxic activities of hydroethanolic, infused and decocted extracts of M. oleifera edible parts. 
  Seeds Student's t-test Flowers Student's t-test Fruits Student's t-test 
  Quinhamel Bissau p-value Quinhamel Bissau p-value Quinhamel Bissau p-value 
Antioxidant activity*           
TBARS (IC50, mg/mL) Hydroethanolic 0.09±0.01c 0.09±0.01c 0.228 0.06±0.01c 0.07±0.01c 0.008 0.15±0.01b 0.14±0.01b 0.471 
 Infusion 0.42±0.01b 0.92±0.01a <0.001 1.23±0.02a 0.99±0.01a <0.001 np np - 
 Decoction 0.51±0.02a 0.82±0.02b <0.001 1.06±0.06b 0.85±0.04b <0.001 1.56±0.02a 1.49±0.05a 0.015 
OxHLIA (IC50, µg/mL) Hydroethanolic na na - na na - na na - 
 Δt = 60 min Infusion 5.1±0.1b 2.4±0.2b <0.001 17.0±0.6b 2.8±0.2b <0.001 np np - 
 Decoction 29±3a 29±2a 0.729 124±2a 89±2a <0.001 265±7 55±3 <0.001 
 Hydroethanolic  na na - na na - na na - 
 Δt = 120 min Infusion               10.1±0.2 b 8.1±0.8 b 0.023 29±1 b 7.8±0.7 b <0.001 np np - 
 Decoction 101±4 a 109±4 a 0.079 222±2 a 160±3 a <0.001 583±26 126±4 <0.001 
Anti-inflammatory activity**          
NO-production inhibition Hydroethanolic 208±14c 180±9c 0.015 >400 >400 - >400 >400 - 
(EC50, μg/mL) Infusion 230±9b 237±6a 0.153 >400 >400 - np np - 
 Decoction 248±4a 230±17b 0.006 >400 >400 - >400 >400 - 
Cytotoxicity to tumour cells***          
HeLa (GI50, μg/mL) Hydroethanolic 160±8c 173±6c 0.001 272±6 300±9 <0.001 >400 >400 - 
(cervical carcinoma) Infusion 201±16b 225±15b 0.272 >400 >400 - np np - 
 Decoction 229±3a 230±17a 0.854 >400 >400 - >400 >400 - 
HepG2 (GI50, μg/mL) Hydroethanolic 95±2c 82±5b 0.060 184±12 222±19 <0.001 > 400 > 400 - 
(hepatocellular carcinoma) Infusion 208±7b 224±14a 0.016 >400 >400 - np np - 
 Decoction 254±6a 224±17a <0.001 >400 >400 - >400 >400 - 
MCF-7 (GI50, μg/mL) Hydroethanolic 167±7c 180±13b 0.001 163±5 187±10 <0.001 >400 >400 - 
(breast carcinoma) Infusion 202±8b 233±5a 0.001 >400 >400 - np np - 
 Decoction 251±7a 232±4a 0.004 >400 >400 - >400 >400 - 
NCI-H460 (GI50, μg/mL) Hydroethanolic 105±10c 129±15b <0.001 245±9 271±13 <0.001 >400 >400 - 
(non-small cell lung cancer) Infusion 232±19b 239±4a 0.414 >400 >400 - np np - 
 Decoction 301±10a 239±6a <0.001 >400 >400 - >400 >400 - 
Cytotoxicity to non-tumour cells***          
PLP2 (GI50, μg/mL) Hydroethanolic 327±8 347±7 0.075 >400 >400 - >400 >400 - 
(porcine liver primary culture) Infusion >400 >400 - >400 >400 - np np - 
 Decoction >400 >400 - >400 >400 - >400 >400 - 
na - no activity; np - not performed. *IC50 values translate the extract concentration providing 50% of antioxidant activity (TBARS assay) or required to keep 50% of the erythrocyte population intact for 60 and 120 
min (OxHLIA assay). Trolox IC50 values: 19.6±0.7 µg/mL (OxHLIA, Δt 60 min), 41±1 µg/mL (OxHLIA, Δt 120 min), and 23 μg/mL (TBARS), **EC50 values translate the extract concentration providing 50% of 
NO-production inhibition. Dexamethasone EC50 value: 16 μg/mL. ***GI50 values correspond to the extract concentration responsible for 50% of cell growth inhibition. Ellipticine GI50 values: 3 µg/mL (PLP2), 1 
µg/mL (MCF-7), 1 µg/mL (NCI-H460), 2 µg/mL (HeLa), and 1 µg/mL (HepG2). In each column, for each variable, different letters correspond to significant differences between extracts (p < 0.05).  
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MIC - minimum inhibitory concentrations; MBC - minimum bactericidal concentration; MFC - minimum fungicidal concentration; np - not performed. 
 
